Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)

v3.21.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Total
Common Stock
Paid in Capital
Retained Earnings/Accumulated (Deficit)
Beginning Balances at Dec. 31, 2019 $ 42,065,916 $ 93,303 $ 40,329,502 $ 1,643,111
Beginning Balance, shares at Dec. 31, 2019   9,330,297    
Restricted stock grants issued   $ 259 (259)  
Restricted stock grants issued, Shares   25,905    
Stock-based compensation 29,162   29,162  
Net income (loss) (356,424)     (356,424)
Dividends (606,469)     (606,469)
Ending Balance at Mar. 31, 2020 41,132,185 $ 93,562 40,358,405 680,218
Ending Balance, shares at Mar. 31, 2020   9,356,202    
Beginning Balances at Dec. 31, 2020 $ 40,038,891 $ 93,431 40,455,409 (509,949)
Beginning Balance, shares at Dec. 31, 2020 9,343,118 9,343,118    
Restricted stock grants issued   $ 635 (635)  
Restricted stock grants issued, Shares   63,475    
Stock-based compensation $ 31,706   31,706  
Net income (loss) 411,247     411,247
Dividends (607,303)     (607,303)
Ending Balance at Mar. 31, 2021 $ 39,874,541 $ 94,066 $ 40,486,480 $ (706,005)
Ending Balance, shares at Mar. 31, 2021 9,406,593 9,406,593